BPC-157 2026 research review — Yildirim ex-vivo human mammary artery vasorelaxation, the 2010-2023 mechanism foundation (Cerovecki, Chang FAK-paxillin, Sikiric), and honest counter-evidence.
What published research says about BPC-157, TB-500, KPV and GHK-Cu: the models each has been studied in, where the human evidence stops, and why no study has tested them in combination.